Evidence map›Paper›PMID 34298796›Full record

ArticleCancers2021

Validation of a Point-of-Care Optical Coherence Tomography Device with Machine Learning Algorithm for Detection of Oral Potentially Malignant and Malignant Lesions.

Bonney Lee James, Sumsum P Sunny, Andrew Emon Heidari, Ravindra D Ramanjinappa, Tracie Lam, Anne V Tran, Sandeep Kankanala, Shiladitya Sil, Vidya Tiwari, Sanjana Patrick and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Bonney Lee JamesIntegrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Sumsum P SunnyIntegrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Andrew Emon HeidariBeckman Laser Institute, UCI, Irvine, CA 92612, USA.
Ravindra D RamanjinappaIntegrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Tracie LamBeckman Laser Institute, UCI, Irvine, CA 92612, USA.
Anne V TranBeckman Laser Institute, UCI, Irvine, CA 92612, USA.
Sandeep KankanalaDepartment of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences, Bangalore 560022, India.
Shiladitya SilDepartment of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences, Bangalore 560022, India.ORCID 0000-0003-2131-1126
Vidya TiwariBiocon Foundation, Bangalore 560100, India.
Sanjana PatrickBiocon Foundation, Bangalore 560100, India.
Vijay PillaiDepartment of Head and Neck Oncology, Mazumdar Shaw Medical Center, NH Health City, Bangalore 560099, India.ORCID 0000-0002-3923-9348
Vivek ShettyDepartment of Head and Neck Oncology, Mazumdar Shaw Medical Center, NH Health City, Bangalore 560099, India.ORCID 0000-0002-9171-7319
Naveen HedneDepartment of Head and Neck Oncology, Mazumdar Shaw Medical Center, NH Health City, Bangalore 560099, India.
Darshat ShahMazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Nameeta ShahMazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Zhong-Ping ChenBeckman Laser Institute, UCI, Irvine, CA 92612, USA.
Uma KandasarmaDepartment of Oral and Maxillofacial Pathology, KLE Society's Institute of Dental Sciences, Bangalore 560022, India.
Subhashini Attavar RaghavanDepartment of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences, Bangalore 560022, India.
Shubha GurudathDepartment of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences, Bangalore 560022, India.
Praveen Birur NagarajIntegrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Petra Wilder-SmithBeckman Laser Institute, UCI, Irvine, CA 92612, USA.
Amritha SureshIntegrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Moni Abraham KuriakoseIntegrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India.
Mazumdar Shaw Medical Foundation · INBeckman Laser Institute and Medical Clinic · USKamineni Institute of Dental Sciences · INMazumdar Shaw Medical Centre · INBiocon (India) · INManipal Academy of Higher Education · IN

Funding

Virtual Photonocs TechnologiesP41EB015890 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI DURKIN, ANTHONY · 2012 to 2017
$7.0M
Department of Biotechnology, Ministry of Science and Technology, India BT/MB/LCMD/04/2012NIH HHS P41EB015890
6 · The paper itself

Abstract

Non-invasive strategies that can identify oral malignant and dysplastic oral potentially-malignant lesions (OPML) are necessary in cancer screening and long-term surveillance. Optical coherence tomography (OCT) can be a rapid, real time and non-invasive imaging method for frequent patient surveillance. Here, we report the validation of a portable, robust OCT device in 232 patients (lesions: 347) in different clinical settings. The device deployed with algorithm-based automated diagnosis, showed efficacy in delineation of oral benign and normal (

Indexed as

artificial neural networkoptical coherence tomographyoral canceroral potentially malignant lesionsoral squamous cell carcinomapre-malignant lesions

Identifiers

PMID34298796
PMCPMC8304149
OpenAlexW3186913661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.